Clinique de Genolier

Dr méd. Jesica Mazza-Stalder

Spécialiste en Pneumologie, membre FMH

Langues
EN FR ES
Spécialités (1)

Contactez-moi

Hôpital, Clinique (1)
Clinique de Genolier
Route du Muids 3
1272 Genolier

Expérience professionnelle

Depuis 2022

Vice president of Vaud Lung League

Depuis 2013

Medical Officer of Public Health for tuberculosis VD (Tuberculosis 10%)

Depuis 2013

Medical Advisor in Respiratory Medicine at the Vaud Lung League (10%)

Depuis 2011

Senior consultant at the Division of Respiratory Medicine (30%) University Hospital of Lausanne Switzerland (CHUV) and private practice in Pulmonary Medicine at Nyon (60% of activity)

2008 - 2011

Chief of Residents, Respiratory Division CHUV

2007 - 2008

Chief of Residents (Chef de Clinique) Thoracic Surgery Division CHUV

2005 - 2007

Respiratory Medicine as MD at University Hospital of Geneva

2004 - 2005

Respiratory Medicine training as a resident (MD) at Rolle Hospital

2001 - 2004

Respiratory Medicine Residency (resident)  at CHUV

1996 - 1999

Chief of Residents and residency of Internal Medicine Central Military Hospital

Compétences

A la suite de ses études de médecine achevées en 1995 à l’Université de Buenos Aires en Argentine (UBA), Jesica Mazza-Stalder se spécialise en médecine interne et commence sa formation de pneumologie à la Fundacion Favaloro à Buenos Aires. Arrivée en Suisse en 2001, elle poursuit sa formation au CHUV, premièrement comme interne de pneumologie au CHUV, ensuite à l’Hôpital de Rolle, puis aux HUG.

En 2007, de retour au CHUV, elle devient chef de clinique dans le Service de chirurgie thoracique, puis dans le service de Pneumologie jusqu’en avril 2011 où elle est nommée médecin agréé.

Les axes de recherche de Jesica Mazza-Stalder concernent la mucoviscidose, la transplantation pulmonaire et la tuberculose. Dans le cadre de son activité au sein du service de pneumologie et en particulier au dispensaire antituberculeux (DAT), des liens ont été établis entre la Ligue pulmonaire vaudoise et la santé publique.

Affiliations

Member of the Board Swiss TB

Vice President of Lung League Vaud 

Depuis 2011

International Union against Tuberculosis and Lung disease

Depuis 2007

Swiss Respiratory Society

Depuis 1999

European Respiratory Society

Formation

2009

Federal Swiss Diploma

2007

Doctorate Unil University of Lausanne Switzerland

2007

FMH Respiratory Medicine

1999

Internal Medicine Specialist (Buenos Aires- Argentina)

1989 - 1995

Medical Doctor education Faculty of Medicine Buenos Aires University (UBA)

Publications

2020

Tadolini, GB Miggliori et al Eur Respir J may 2020
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

2019

Borisov S, et al….Mazza-Stalder J, Nicod LP, Miggliori GB Eur Respir J 2019 Dec 19,54 (6) Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

2019

J Mazza-Stalder, E Chevallier, O Opota, A Carreira, K Jaton, E Masserey, J P Zellweger, L P Nicod. Frontiers in Medicine. Published June 2019. Improvement in tuberculosis outcomes with a combined medical and social approach

2019

Opota O, Mazza-Stalder J, Greub G, Jaton K.  The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection. Clinic Microbiol Infection 2019 Nov  doi: 10.1016/j.cmi.2019.03.021. Epub 2019 Mar 28

2019

Zakham F1, Laurent S1, Esteves Carreira AL2, Corbaz A2, Bertelli C1, Masserey E3, Nicod L2, Greub G1, Jaton K1, Mazza-Stalder J2, Opota O1. New Microbes New Infect. 2019 Jun 29; 31:100582. doi: 0.1016/j.nmni.2019.100582. eCollection 2019 Sep. Whole-genome sequencing for rapid, reliable and routine investigation of Mycobacterium tuberculosis transmission in local communities

2019

Simon A, Opota O, Mazza-Stalder J, Nicod L, Greub G, Nicod L, Jaton K. Added diagnostic value of 16S rRNA gene pan mycobacterial for nontuberculous mycobacterial infections: a 10 year retrospective study

2018

O Opota, F Zakham, J Mazza-Stalder, L Nicod, G Greub, K Jaton. Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low Prevalence Setting. J Clin Microbiol 2018 57:e01717-18

2018

Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD, van der Werf MJ, and the MDR-TB Cluster Consortium. A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. Lancet Infect Dis. 2018;18(4):431-40

2016

Opota O, Senn L, Prod'hom G, Mazza Stalder J, Tissot F, Greub G, Jaton K. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country. Clin Microbiol Infect. 2016 Jul;22(7):613-9. doi: 10.1016/j.cmi.2016.04.010. Epub 2016 Apr 29

2016

Stucki D, Ballif M, Egger M, Furrer H, Altpeter E, Battegay M, Droz S, Bruderer T, Coscolla M, Borrell S, Zürcher K, Janssens JP, Calmy A, Mazza Stalder J, Jaton K, Rieder HL, Pfyffer GE, Siegrist HH, Hoffmann M, Fehr J, Dolina M, Frei R, Schrenzel J, Böttger EC, Gagneux S, Fenner L. Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country.J Clin Microbiol. 2016 Jul;54(7):1862-70. doi: 10.1128/JCM.00126-16.

2015

Rozot V, Amelio P, Vigano S, Mazza-Stalder J, Idrizi E, Day Cheryl, Perreau M, Lazor-Blanchet C, Ohmiti K, Goletti D, Bart P. A, Hanekom W, Scriba Th, Nicod L, Pantaleo G et Harari A. Clinical infectious disease 2015. Combined Use of M Tuberculosis-specific CD4 and CD8 T cell is a Powerful Diagnostic tool of Active Tuberculosis

2013

Bridevaux P-O, Aubert J-D, Soccal P M, Mazza-Stalder J, Berutto C, Rochat T, Turin L, Van Belle, Nicod L. P et al Thorax september 2013 Incidence and Outcomes of respiratory viral infections in lung transplant recipients: a prospective study

2013

Perreau M, Rozot V, Welles HC, Belluti-Enders F, Vigano S, Maillard M, Dorta G, Mazza-Stalder J, Bart PA, Roger T, Calandra T, Nicod L, Harari A. Eur J Immunol. 2013 Apr; 43(4):939-48. Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+T cells in active disease

2013

Rozot V, Mazza-Stalder J, Nicod L. P, Harari A. et al EJI 2013. Mycobacterium tuberculosis-specific CD8+ T Cells are functionally and phenotypically different between latent infection and active disease

2012

Mazza-Stalder J, Nicod L., Janssens JP. Revue des Maladies respiratoires avril 2012. La tuberculose extra-pulmonaire

2011

Harari A, R Rozot V, Bellutti Enders F,  Perreau M,  Mazza-Stalder J,  Nicod L., Cavassini M,  Calandra Th, Lazor Blanchet K, Jaton K,  Faouzi M, Day Ch, Willem A. Hanekom, Bart P-A and  Pantaleo G. Nature Med 2011. Dominant TNF-a Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses Discriminate Between Latent Infection and Active Disease

2010

Uçkay I, Gasche-Soccal PM, Kaiser L, Stern R, Mazza-Stalder J, Aubert JD, van Delden C. J Heart Lung Transplant. 2010 Mar; 29(3):299-305. Epub 2009 Oct 17. Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy

2010

Boillat Blanco N, Kuonen R, Bellini C, Manuel O, Estrade C, Mazza-Stalder J, Aubert JD, Sahli R, Meylan P. Transpl Infect Dis. 2010 Aug 30. Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient

2009

Mazza-Stalder J, Lador F, Soccal-Gasche P, Aubert J. Evaluation of pulmonary arterial pressure in lung transplant candidates: transthoracic echocardiographie versus right heart catheterization. « Meilleur poster à la Société suisse d’hypertension pulmonaire ». ERS Vienna 2009/ and 4th International Congress of the Swiss Society for Pulmonary Hypertension. SSPH Zurich 2009: Best Poster

2009

Mazza-Stalder J, Janton-Ogay K, Nicod L. Revue medicale Suisse nov 2009. Non tuberculous mycobacteria pulmonary disease: what's new? 

2008

Mazza-Stalder J, Sistek, J. P. Revelly, S. D. Qanadli, A. Sauty. Massive haemoptysis in cystic fibrosis adult patients. ERS 2008. P1244. 5.10.2008

2005

Mazza-Stalder J, Siegrist CA, Janssens JP. Rev Med Suisse. 2005 Nov 16; 1(41):2645-6, 2649-51. Immunization and immuno-modulation for prevention of respiratory tract infections

2003

Mazza-Stalder J, Sauty A. 48h-continuous interstitial glucose monitoring in non-diabetic cystic fibrosis patients: a pilot study. Journal of Cystic Fibrosis 2 (suppl1), pp. S79, 2003

2003

Mazza-Stalder J, Sauty A. Le syndrome hépatopulmonaire (SHP). Médecine et hygiène 2458, 12 nov 2003

2002

Mazza-Stalder J, Sauty A. Significance of macrophage predominance in pleural effusions. Oral presentation ERS congress Schweiz Med Forum suppl 7, pp 20S 2002

Médecins avec cette spécialisation

fallback-image
Clinique Générale-Beaulieu

Dr méd. Alexander B. Pavlovic

Spécialisation
Pneumologie
Privatklinik Bethanien

Dr méd. Tobias Herren

Spécialisation
Pneumologie, Médecine interne
fallback-image
Privatklinik Obach

Dr méd. Patricia Demont

Spécialisation
Pneumologie
Privatklinik Bethanien

Dr méd. Christoph Tuor

Spécialisation
Pneumologie, Médecine interne
Hôpital de La Providence

Dr méd. Véronique Negrel

Spécialisation
Pneumologie
Privatklinik Bethanien

Dr méd. Thomas Scherer

Spécialisation
Pneumologie, Médecine interne